English

Postponed reimbursement process for Glucomed in France

Report this content
(Lysaker, Norway, 12 June 2008) Navamedic has been informed that the reimbursement process in France is delayed. As a consequence, it is uncertain whether Glucomed will be launched in France during 2008.




For further information, please contact:



Øyvind W. Brekke, CEO Navamedic ASA
E-mail: oyvind.brekke@navamedic.com
Office: +47 67 11 25 40
Mobile: +47 91 19 81 64



Bernt-Olav Røttingsnes, CFO/IRO Navamedic ASA
E-mail: bor@navamedic.com
Office: +47 67 11 25 44
Mobile: +47 91 34 70 21


Subscribe